Gloport Photonix: Empowering Healthcare Services with Cutting-Edge Photonic Innovations

Our devices don’t disrupt clinical workflows, they dissolve barriers to access and accuracy. At the core of it all: Innovation happens when photons meet purpose. That’s our DNA”, adds Abhijeet.

Driven by innovation, Gloport Photonix has developed India’s first photoacoustic breath analyzer for early cancer detection. It is also a leading organization in the domain, building its own indigenous laser packaging and precision detector modules to break import dependence. Developing a range of novel solutions, the company has filed multiple global patents in sensing, signal processing, and AI-based diagnostics and even established India’s first dedicated Photonics Healthcare Deep-Tech Lab. The lab, located in Navi Mumbai is bridging lab-to-market for life-saving innovations.

In this mission, the firm is powered by automation and smart technologies, which fuel precision as well as scale. For the purpose of manufacturing, the company utilized optical tables, automated alignment systems, and precision mounts. These integrations help the

team achieve micrometer-level accuracy in assembling photonic components. Further, the process of calibration is supported by smart self-learning algorithms continuously auto-correct sensor drift. These help in ensuring stable performance over time, and ensuring success consistently. When it comes to deployment, the firm ensures that its devices auto-sync with cloud health dashboards, offering doctors real-time access to diagnostic insights.

Expertise That Nurtures Long-Term Relationships

With a founding team that brings a combined 50+ years of experience in diversified fields including photonics, AI, precision manufacturing, global product launches and healthcare strategy, Gloport Photonix is equipped with deep industry insight.

“From IIT and DRDO scientists to ex JP Morgan Global Tech Leaders, Oncologists and Veteran clinicians, we are a convergence of domain depth and operational excellence. We work tirelessly to research and develop new technologies that enhance diagnostic capabilities and improve patient outcomes. When the world looks for what’s next, we’re already building it, with purpose and scalability”, adds Dr Alok Verma, Co-Founder & CTO, Gloport Photonix.

But, it's not just the core leadership that excels in the domain. The company is equipped with a very strong team across verticals, including a robust support team. Strengthened by an expert team, the firm offers comprehensive support for remote diagnostics and predictive maintenance, 24x7 clinical helpline, in-field engineers and cloud-based performance dashboards, and regular clinical validation updates and feature rollouts. Treating support as its second innovative product, the company strives to build relationships with every device installed, ensuring seamless operations in the long term.

Valuing customer experiences and relationships, Gloport Photonix operates on three key principles: evidence over promises, partner beyond sales, and customization over standardization. Its practices and policies are designed to extend beyond mere transactional relationships. Not just selling products, Gloport Photonix strives to co-own patient outcomes by providing clients with data-backed decisions, ongoing calibration, training, and partnership in innovation.

“We draw inspiration from the workers across coal and iron ore mines, as well as those working in dusty environments like cement, steel, and thermal power plants, who are more susceptible to lung cancer & TB. These under privileged workers are backbone of economy. Our vision is to democratize the diagnosis of cancer and tuberculosis in its very early stages at their doorsteps to enable them have cost-effective treatment leading to zero threat to their lives shares”, says Sanjay Singh, Co-Founder & CBO, Gloport Photonix.

Journey to Excellence

Gloport Photonix has covered a remarkable journey so far, one driven by passion and commitment to innovation. From a lab prototype to field-validated deployments in hospitals across India, the company’s growth has been rapid, establishing its prominence and excellence. In the time since its inception, the company has secured multiple MOUs with hospitals and universities, raised initial rounds to scale production and trials, and reached TRL 7–8 on its flagship products. The firm has also successfully partnered for clinical trials with institutions like Manipal and other big cancer hospitals, becoming a trusted name in the industry.

But its journey has not focused on simply scaling. Gloport Photonix has eyes on a bigger prize: to grow deep for impact. In this journey which has just begun, the company is focused on a singular goal to transform the global healthcare landscape by enabling early-stage disease detection, particularly in cancer diagnostics, and delivering breakthrough innovations that push the boundaries of medical science.

“Early diagnosis saves lives, and at Gloport Photonix, we are pioneering new ways to detect diseases before symptoms arise. We are dedicated to continuous improvement and innovation, ensuring that our solutions meet the evolving needs of healthcare professionals and patients alike. From Make-in-India to Scale-for-the-World, that’s our trajectory”, adds Abhijeet Thakur, Co-Founder & CEO, Gloport Photonix.

In line with its future objectives, the company plans to be laser-focused on the commercial rollout for its breath-based diagnostics across Tier 1–3 cities, indigenization of Critical photonics components, and global expansion into Cancer screening markets in SE Asia, Africa, Europe and the UAE. Alongside this, it also aims to build India’s first full-stack Photonics Manufacturing Lab for MedTech.

More in store, the company is set to launch India’s first Photonics Breath Scan PBS Scan, India’s first AI-integrated, Non-invasive diagnostic platform using breath-based VOC signatures. On a concluding note, Abhijeet Thakur shares, “Photonics isn’t just light science, it’s Life Science. If you can master light, you can decode disease, detect cancer, and transform lives, without ever drawing a single drop of blood. We are where the boldest ideas, the toughest challenges, and the wildest deep-tech dreams come alive”.